$EW
Edwards Lifesciences Corp Stock $ew

$ew Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000109980015000036 Filed on October 29, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q4
Revenue	$671.1M	$615.5M	$618.0M
YoY Change	8.59%	1.33%	15.3%
Cost Of Revenue	$175.9M	$146.7M	$160.4M
YoY Change	9.66%	-12.73%	11.54%
Gross Profit	$495.2M	$468.8M	$457.6M
YoY Change	8.22%	6.72%	17.18%
Gross Profit Margin	73.79%	76.17%	74.05%
Selling, General & Admin	$222.3M	$212.0M	$223.1M
YoY Change	-0.36%	-4.59%	19.56%
% of Gross Profit	44.89%	45.22%	48.75%
Research & Development	$98.20M	$101.0M	$84.00M
YoY Change	16.9%	15.3%	6.87%
% of Gross Profit	19.83%	21.54%	18.36%
Depreciation & Amortization	$14.50M	$18.50M	$18.30M
YoY Change	-20.77%	2.78%	40.77%
% of Gross Profit	2.93%	3.95%	4.0%
Operating Expenses	$321.1M	$313.0M	$307.0M
YoY Change	4.59%	1.03%	16.11%
Operating Profit	$174.1M	$155.8M	$150.6M
YoY Change	15.6%	20.31%	19.43%
Interest Expense	-$3.800M	-$2.500M	-$6.900M
YoY Change	-44.93%	0.0%	56.82%
% of Operating Profit	-2.18%	-1.6%	-4.58%
Other Income/Expense, Net		-$200.0K
YoY Change
Pretax Income	$167.0M	$150.7M	$132.9M
YoY Change	25.66%	24.96%	32.5%
Income Tax	$26.30M	$32.60M	$23.70M
% Of Pretax Income	15.75%	21.63%	17.83%
Net Earnings	$140.7M	$118.1M	$109.2M
YoY Change	28.85%	24.84%	45.41%
Net Earnings / Revenue	20.97%	19.19%	17.67%
Basic Earnings Per Share	$0.65	$0.55	$0.51
Diluted Earnings Per Share	$0.64	$0.54	$0.50
COMMON SHARES
Basic Shares Outstanding	107.9M shares	215.2M shares
Diluted Shares Outstanding		219.9M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.225B	$1.251B	$1.439B
YoY Change	-14.88%	-17.46%	53.57%
Cash & Equivalents	$718.4M	$646.1M	$653.8M
Short-Term Investments	$506.3M	$604.4M	$785.0M
Other Short-Term Assets	$66.40M	$96.60M	$121.7M
YoY Change	-45.44%	7.81%	69.5%
Inventory	$339.9M	$333.5M	$296.8M
Prepaid Expenses	$45.10M	$47.50M	$48.80M
Receivables	$315.4M	$338.4M	$288.0M
Other Receivables	$56.40M	$0.00	$37.00M
Total Short-Term Assets	$2.048B	$2.146B	$2.231B
YoY Change	-8.21%	-7.09%	29.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$482.5M	$454.8M	$442.9M
YoY Change	8.94%	5.94%	5.05%
Goodwill	$628.3M	$621.2M	$376.0M
YoY Change	67.1%	63.91%	-2.44%
Intangibles	$205.4M	$207.3M	$23.40M
YoY Change	777.78%	703.49%	-30.15%
Long-Term Investments	$6.700M	$7.600M	$9.300M
YoY Change	-27.96%	-24.0%	-18.42%
Other Assets	$131.8M	$54.90M	$49.20M
YoY Change	167.89%	44.85%	38.98%
Total Long-Term Assets	$2.008B	$1.731B	$1.292B
YoY Change	55.46%	66.32%	31.28%
TOTAL ASSETS
Total Short-Term Assets	$2.048B	$2.146B	$2.231B
Total Long-Term Assets	$2.008B	$1.731B	$1.292B
Total Assets	$4.056B	$3.877B	$3.523B
YoY Change	15.14%	15.72%	30.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$63.90M	$71.50M	$58.20M
YoY Change	9.79%	19.37%	20.25%
Accrued Expenses	$378.4M	$267.9M	$340.0M
YoY Change	11.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$476.2M	$532.5M	$426.1M
YoY Change	11.76%	24.47%	23.29%
LONG-TERM LIABILITIES
Long-Term Debt	$596.9M	$604.9M	$598.1M
YoY Change	-0.2%	1.43%	0.84%
Other Long-Term Liabilities	$285.4M	$317.8M	$112.6M
YoY Change	153.46%	12.54%	-50.35%
Total Long-Term Liabilities	$882.3M	$922.7M	$710.7M
YoY Change	24.15%	5.0%	-13.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$476.2M	$532.5M	$426.1M
Total Long-Term Liabilities	$882.3M	$922.7M	$710.7M
Total Liabilities	$1.359B	$1.455B	$1.137B
YoY Change	19.5%	11.37%	-2.46%
SHAREHOLDERS EQUITY
Retained Earnings	$3.337B	$3.196B	$2.842B
YoY Change	17.41%	16.96%	39.94%
Common Stock	$1.186B	$1.132B	$1.007B
YoY Change	17.73%	20.63%	26.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.837B	$1.737B	$1.557B
YoY Change	17.99%	11.58%	23.96%
Treasury Stock Shares	23.70M shares	22.50M shares	21.10M shares
Shareholders Equity	$2.503B	$2.421B	$2.191B
YoY Change
Total Liabilities & Shareholders Equity	$4.056B	$3.877B	$3.523B
YoY Change	15.14%	15.72%	30.0%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q4
OPERATING ACTIVITIES
Net Income	$140.7M	$118.1M	$109.2M
YoY Change	28.85%	24.84%	45.41%
Depreciation, Depletion And Amortization	$14.50M	$18.50M	$18.30M
YoY Change	-20.77%	2.78%	40.77%
Cash From Operating Activities	$103.8M	$202.5M	$93.20M
YoY Change	11.37%	1559.84%	-16.26%
INVESTING ACTIVITIES
Capital Expenditures	-$41.30M	-$26.00M	-$45.30M
YoY Change	-8.83%	43.65%	119.9%
Acquisitions
YoY Change
Other Investing Activities	$68.60M	-$149.6M	$157.3M
YoY Change	-56.39%	9.44%	-169.51%
Cash From Investing Activities	$27.30M	-$175.6M	$112.0M
YoY Change	-75.63%	13.44%	-145.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-59.70M	23.60M	45.90M
YoY Change	-230.07%	-51.54%	-42.98%
NET CHANGE
Cash From Operating Activities	103.8M	202.5M	93.20M
Cash From Investing Activities	27.30M	-175.6M	112.0M
Cash From Financing Activities	-59.70M	23.60M	45.90M
Net Change In Cash	71.40M	50.50M	251.1M
YoY Change	-71.57%	-153.78%	-555.72%
FREE CASH FLOW
Cash From Operating Activities	$103.8M	$202.5M	$93.20M
Capital Expenditures	-$41.30M	-$26.00M	-$45.30M
Free Cash Flow	$145.1M	$228.5M	$138.5M
YoY Change	4.77%	654.13%	5.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	ew	Payments To Acquire Proceeds From Sale Of Trading Securities Heldforinvestment PaymentsToAcquireProceedsFromSaleOfTradingSecuritiesHeldforinvestment	6300000	USD
	dei	Entity Registrant Name EntityRegistrantName	Edwards Lifesciences Corp
CY2014Q4	ew	Accrual For Property Payroll And Other Taxes Other Than Income Taxes Current AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent	32700000	USD
CY2015Q3	ew	Accrual For Property Payroll And Other Taxes Other Than Income Taxes Current AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent	33600000	USD
CY2014Q4	ew	Accrued Rebates AccruedRebates	11700000	USD
CY2015Q3	ew	Accrued Rebates AccruedRebates	21000000	USD
CY2014Q4	ew	Cumulative Income Loss From Equity Method Investments CumulativeIncomeLossFromEquityMethodInvestments	-3500000	USD
CY2015Q3	ew	Cumulative Income Loss From Equity Method Investments CumulativeIncomeLossFromEquityMethodInvestments	-3500000	USD
CY2014Q4	ew	Employee Compensation And Withholdings EmployeeCompensationAndWithholdings	190500000	USD
CY2015Q3	ew	Employee Compensation And Withholdings EmployeeCompensationAndWithholdings	174800000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001099800
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	107854829	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q3	ew	Intellectual Property Litigation Income Expense Net IntellectualPropertyLitigationIncomeExpenseNet	-900000	USD
	ew	Intellectual Property Litigation Income Expense Net IntellectualPropertyLitigationIncomeExpenseNet	741000000	USD
CY2015Q3	ew	Intellectual Property Litigation Income Expense Net IntellectualPropertyLitigationIncomeExpenseNet	-2400000	USD
	ew	Intellectual Property Litigation Income Expense Net IntellectualPropertyLitigationIncomeExpenseNet	-3700000	USD
CY2014Q3	ew	Other Income Expense OtherIncomeExpense	-2500000	USD
	ew	Other Income Expense OtherIncomeExpense	-2600000	USD
CY2015Q3	ew	Other Income Expense OtherIncomeExpense	-200000	USD
	ew	Other Income Expense OtherIncomeExpense	-2200000	USD
	ew	Payments For Proceeds From Interest In Subsidiaries And Affiliates PaymentsForProceedsFromInterestInSubsidiariesAndAffiliates	1000000	USD
	ew	Payments For Proceeds From Interest In Subsidiaries And Affiliates PaymentsForProceedsFromInterestInSubsidiariesAndAffiliates	-800000	USD
	ew	Payments To Acquire Proceeds From Sale Of Trading Securities Heldforinvestment PaymentsToAcquireProceedsFromSaleOfTradingSecuritiesHeldforinvestment	11800000	USD
CY2014Q4	ew	Reduction In Liabilities For Unrecognized Tax Benefits ReductionInLiabilitiesForUnrecognizedTaxBenefits	34300000	USD
CY2015Q3	ew	Reduction In Liabilities For Unrecognized Tax Benefits ReductionInLiabilitiesForUnrecognizedTaxBenefits	37900000	USD
CY2014Q4	ew	Researchand Development Accruals ResearchandDevelopmentAccruals	39900000	USD
CY2015Q3	ew	Researchand Development Accruals ResearchandDevelopmentAccruals	38500000	USD
CY2014Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	325000000	USD
CY2015Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	338400000	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	434400000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	13300000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7400000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.49
CY2015Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	532500000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	58200000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	71500000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	5800000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	5500000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	9100000	USD
CY2015Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	9700000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-100900000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-169200000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	878400000	USD
CY2015Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1001300000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12200000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	36100000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12600000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	37000000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5100000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8200000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	6200000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	5500000	USD
CY2014Q4	us-gaap	Assets Assets	3524300000	USD
CY2015Q3	us-gaap	Assets Assets	3876600000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	2294600000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	2145500000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2015Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	300000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	400000	USD
CY2015Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	800000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	160500000	USD
CY2015Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	345100000	USD
CY2014Q4	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	400000	USD
CY2015Q3	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	200000	USD
CY2014Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	0	USD
CY2015Q3	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	0	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	46900000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	46900000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis	1500000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue	1500000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	231500000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	231000000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	65200000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	65200000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	160100000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	344600000	USD
CY2014Q4	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	400000	USD
CY2015Q3	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	200000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9900000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	420400000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	404100000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	653800000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	646100000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-16300000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7700000	USD
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	17800000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000.0	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000.0	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	128900000	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	130200000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107800000	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107700000	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	128900000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	130200000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	65100000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	658900000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	95500000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	285900000	USD
CY2014Q4	us-gaap	Cost Method Investments CostMethodInvestments	16700000	USD
CY2015Q3	us-gaap	Cost Method Investments CostMethodInvestments	19800000	USD
CY2014Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	168100000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	465200000	USD
CY2015Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	146700000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	441300000	USD
CY2014Q1	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	3500000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	63500000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	79000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	91500000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	21400000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	8300000	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	10100000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	50300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	51300000	USD
CY2014Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2600000	USD
CY2015Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	11700000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.89
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.61
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.29
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.87
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.22
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-1500000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-11300000	USD
CY2014Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.216
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.306
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.216
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.222
CY2015Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	102200000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P32M
CY2014Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	12800000	USD
CY2015Q3	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	11100000	USD
CY2014Q4	us-gaap	Equity Method Investments EquityMethodInvestments	9300000	USD
CY2015Q3	us-gaap	Equity Method Investments EquityMethodInvestments	7600000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	34200000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	27100000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	34200000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	27100000	USD
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	30300000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2800000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	2500000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	376000000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	621200000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	439300000	USD
	us-gaap	Gross Profit GrossProfit	1239700000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	468800000	USD
	us-gaap	Gross Profit GrossProfit	1381300000	USD
CY2014Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	839400000	USD
CY2015Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	598200000	USD
CY2014Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	100000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	100000	USD
CY2014Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	100000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	100000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Debt Maturities Next Rolling Twelve Months Fair Value HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	557500000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Debt Maturities Rolling Year Six Through Ten Fair Value HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue	0	USD
CY2015Q3	us-gaap	Held To Maturity Securities Debt Maturities Rolling Year Two Through Five Fair Value HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	26800000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	13900000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount	13900000	USD
CY2014Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	839400000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	598200000	USD
CY2015Q3	us-gaap	Heldtomaturity Securities Debt Maturities Next Rolling Twelve Months Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost	557500000	USD
CY2015Q3	us-gaap	Heldtomaturity Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost	0	USD
CY2015Q3	us-gaap	Heldtomaturity Securities Debt Maturities Rolling Year Two Through Five Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost	26800000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	120600000	USD
CY2015Q3	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	37800000	USD
CY2014Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	4400000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1011100000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	150700000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	455400000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	309200000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	101200000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	200300000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	37200000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	10700000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	28300000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	91800000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	35900000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	112500000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	63900000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	3800000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1100000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	56100000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-3000000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	100000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6300000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8900000	USD
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2000000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1900000	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2400000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2400000	shares
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23400000	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	207300000	USD
CY2014Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2500000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-9100000	USD
CY2015Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2500000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-6700000	USD
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	170100000	USD
CY2015Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	195300000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	296800000	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	333500000	USD
CY2014Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	67400000	USD
CY2015Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	70200000	USD
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	59300000	USD
CY2015Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	68000000	USD
CY2014Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	26400000	USD
CY2015Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	27600000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3524300000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3876600000	USD
CY2014Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	USD
CY2015Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	6100000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	598100000	USD
CY2015Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	604900000	USD
CY2014Q4	us-gaap	Long Term Investments LongTermInvestments	240900000	USD
CY2015Q3	us-gaap	Long Term Investments LongTermInvestments	366000000	USD
	us-gaap	Maximum Length Of Time Foreign Currency Cash Flow Hedge MaximumLengthOfTimeForeignCurrencyCashFlowHedge	P13M
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-198900000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-98900000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-745000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-343400000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	929100000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	445900000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	94600000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	701900000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	118100000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	354200000	USD
CY2014Q4	us-gaap	Noncurrent Assets NoncurrentAssets	492100000	USD
CY2015Q3	us-gaap	Noncurrent Assets NoncurrentAssets	509700000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	69300000	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	116000000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	121700000	USD
CY2015Q3	us-gaap	Other Assets Current OtherAssetsCurrent	96600000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	49200000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	54900000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	23800000	USD
	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	16400000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-15500000	USD
	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-14800000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-53400000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-59600000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-6900000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-53200000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-29500000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-29500000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-43000000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-22600000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-68300000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax	300000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax	400000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax	800000	USD
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-10300000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	100000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-100000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-600000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1100000	USD
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0	shares
CY2015Q3	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	0	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	0	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1600000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	1700000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	300700000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	180100000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	307200000	USD
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	48800000	USD
CY2015Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	47500000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	320100000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	220300000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	20700000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-5000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-7800000	USD
CY2014Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	46200000	USD
CY2015Q3	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	58000000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	300400000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	317800000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4700000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9900000	USD
CY2014Q3	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	3000000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	60500000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	1600000000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	903500000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48400000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	65200000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0	shares
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	126300000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	912600000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	1135100000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	71300000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	60000000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	442900000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	454800000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	49100000	USD
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	219000000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	18800000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	87600000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	262500000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	101000000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	284900000	USD
CY2014Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	7700000	USD
CY2015Q3	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1700000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2841900000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3196100000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	607400000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1704900000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	615500000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1822600000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	222200000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	634900000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	212000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	628400000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	36100000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	37000000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	900000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	132.31
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	785000000	USD
CY2015Q3	us-gaap	Short Term Investments ShortTermInvestments	604400000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	2191400000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	2421400000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	21100000	shares
CY2015Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	22500000	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1556900000	USD
CY2015Q3	us-gaap	Treasury Stock Value TreasuryStockValue	1737000000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	192300000	USD
CY2015Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	212400000	USD
CY2014Q2	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	6200000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	158000000	USD
CY2015Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	174500000	USD
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108100000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110100000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106400000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106200000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107600000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107700000	shares

Files In Submission

Name	View Source	Status
0001099800-15-000036-index-headers.html	Edgar Link	pending
0001099800-15-000036-index.html	Edgar Link	pending
0001099800-15-000036.txt	Edgar Link	pending
0001099800-15-000036-xbrl.zip	Edgar Link	pending
ew-20150930.xml	Edgar Link	completed
ew-20150930.xsd	Edgar Link	pending
ew-20150930_cal.xml	Edgar Link	unprocessable
ew-20150930_def.xml	Edgar Link	unprocessable
ew-20150930_lab.xml	Edgar Link	unprocessable
ew-20150930_pre.xml	Edgar Link	unprocessable
ew10-qq32015.htm	Edgar Link	pending
ew10-qq320_chartx00799.jpg	Edgar Link	pending
ew10-qq320_chartx58097.jpg	Edgar Link	pending
ew10-qq320_chartx59466.jpg	Edgar Link	pending
ex-10110xqq32015.htm	Edgar Link	pending
ex-31110xqq32015.htm	Edgar Link	pending
ex-31210xqq32015.htm	Edgar Link	pending
ex-3210xqq32015.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EW
Edwards Lifesciences Corp Stock $ew

2015 Q4 Form 10-Q Financial Statement

#000109980015000036 Filed on October 29, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW Edwards Lifesciences Corp Stock $ew

2015 Q4 Form 10-Q Financial Statement

#000109980015000036 Filed on October 29, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW
Edwards Lifesciences Corp Stock $ew